Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
61.44 USD | +1.02% |
|
-3.52% | +11.43% |
02/07 | ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets | MT |
02/07 | ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.43% | 1.19B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- ANI Pharmaceuticals Insider Sold Shares Worth $141,090, According to a Recent SEC Filing